Thomas Poletti and Katherine Blair, partners in the Manatt’s capital markets group, advised A.G.P./Alliance Global Partners as sole placement agent in a $9.5 million registered direct offering of Class B Subordinate Voting Shares and warrants for FSD Pharma Inc., a Canadian company that trades on Nasdaq and the Canadian Securities Exchange.
FSD Pharma, through its wholly-owned subsidiary, is a specialty biotech pharmaceutical R&D company focused on developing over time multiple applications of its lead compound FSD-201, by down-regulating the cytokines to effectuate an anti-inflammatory response.
The Manatt team, led by Poletti and Blair, also included associate Jonathan Brecher. More information about the registered direct offering may be found here.
Previously, the Manatt team represented A.G.P. in its role as sales agent in a $20 million at-the-market offering, lead placement agent in a $7.5 million private placement and sole placement agent in a $10 million registered direct offering for FSD Pharma Inc.